Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
(OP:
CELV
)
0.1000
+0.0100 (+11.11%)
Streaming Delayed Price
Updated: 3:27 PM EST, Jan 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CELV
Cellev8 Nutrition Welcomes Dr. Guangshuo "Alan" Zhu, MD to Its Board of Directors
January 08, 2026
Via
ACCESS Newswire
Cellev8 Nutrition(TM) and NFL Legend Andre Reed Launch Groundbreaking Partnership at Super Bowl, Revolutionizing Cellular Health in Sports
February 11, 2025
Via
ACCESS Newswire
Cellev8 Nutrition Teams Up With NFL Hall of Famer Andre Reed to Revolutionize Wellness, on and Off the Field
January 15, 2025
Via
ACCESSWIRE
Cellev8 Nutrition Files Two Patents at US Trademark and Patent Office
December 17, 2024
Via
ACCESSWIRE
Cellev8 Nutrition Launches the First GLP1 Support Gummy With Clinically Tested Ingredients
December 12, 2024
Via
ACCESSWIRE
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress
December 10, 2024
Via
ACCESSWIRE
Cellev8 Nutrition Shareholder Update
November 07, 2024
Via
ACCESSWIRE
Cellev8 and Zyppah Team Up to Give Snoring a Rest
October 29, 2024
Via
ACCESSWIRE
Cellev8 Nutrition Inc (Formerly Preferred Commerce) Clarifies Business Focus and Highlights Benefits of Superoxide Dismutase Supplements
November 14, 2024
Via
ACCESSWIRE
Cellev8, the First SOD Product Shatters the Mold with NSF Certified for Sport Accreditation, Paving the Way for Unprecedented Cellular Performance Supplements!
September 19, 2023
Via
ACCESSWIRE
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.